GLP-1 drugs are quietly reshaping how America shops and eats
More than 20% of US households now include at least one GLP-1 user, and the ripple effects on grocery spending, fast food, fashion, and beauty products are accelerating faster than any consumer shift in recent memory. When Megan McDonald started taking the GLP-1 drug Zepbound two years ago, she was not thinking about […]
Ozempic’s New Pill Form Could Change Who Has Access
Novo Nordisk has begun selling an oral version of semaglutide in the United States under the Ozempic name, a move that extends one of the most recognized drug brands in recent memory into a format that does not require an injection. The pill became available on May 4, 2026, at more than 70,000 pharmacies nationwide, […]
Weight loss shown to reverse heart muscle damage caused by severe obesity
New research in Science found that losing 10% of body weight through GLP-1 therapy restored near-normal heart muscle function in patients with obesity-related heart failure. For years, the medical community has understood that obesity strains the heart. What has been less clear is whether that strain can be undone. A […]
DIY peptide injections are sending people to the ER
What started as a niche interest among bodybuilders has quietly spread to suburban moms, white collar professionals and affluent antiaging enthusiasts and now doctors at high-end longevity clinics are dealing with the fallout. People are increasingly sourcing injectable peptides online, from grey market sellers, or secondhand from friends treating the practice. A peptide is a […]
New study finds 1 gene variant that boosts GLP-1 results
GLP-1 receptor agonists like semaglutide and tirzepatide have become some of the most talked about medications in modern medicine, reshaping how millions of people approach weight loss. But a sweeping new study suggests that the results people experience may have less to do with willpower or lifestyle and more to do with what is written […]
Wegovy is rewriting the rules of cardiovascular care with a groundbreaking new approval
Wegovy, the injectable medication best known for its role in weight management, has just been cleared for a purpose that extends well beyond the scale. Britain’s national health technology authority has recommended Wegovy for use in reducing the risk of major cardiovascular events, including heart attacks, strokes, and cardiovascular death, in adults who are living […]
Nutritional guidelines for GLP-1 medication users
Recent studies have highlighted the importance of tailored nutritional guidelines for individuals using GLP-1 medications for weight loss. These drugs, effective in reducing appetite and aiding significant weight loss, include FDA-approved Wegovy and others like Ozempic and Saxenda used off-label. However, the reduced food intake associated with these medications raises concerns about potential nutritional deficiencies. […]